2,051.70
+27.70
+(1.37%)
As of 1:13:00 PM CST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 6 | 25 | 25 |
| Avg. Estimate | 15.51B | 16.28B | 64.01B | 67.41B |
| Low Estimate | 15.32B | 15.65B | 63.15B | 65.86B |
| High Estimate | 15.82B | 16.96B | 64.36B | 70.95B |
| Year Ago Sales | 14.63B | 15.78B | 60.12B | 64.01B |
| Sales Growth (year/est) | 6.04% | 3.20% | 6.48% | 5.31% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRK.MX | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 1/28/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/21/2025 |
| Maintains | Leerink Partners: Outperform to Outperform | 1/13/2025 |
| Maintains | UBS: Buy to Buy | 1/8/2025 |
| Downgrade | Truist Securities: Buy to Hold | 1/8/2025 |
| Downgrade | BMO Capital: Outperform to Market Perform | 12/20/2024 |
Related Tickers
GIS.F Gilead Sciences, Inc.
93.31
+0.43%
SNW2.MU Sanofi SA
52.00
+1.96%
JNJ.MX Johnson & Johnson
3,149.95
-0.63%
1SAN.MI Sanofi
104.08
+0.48%
JNJ.HM Johnson & Johnson
146.36
+0.26%
LLY.MU Eli Lilly and Co
791.10
+2.42%
NOVN.SW Novartis AG
95.58
+1.90%
ROG.SW Roche Holding AG
286.00
+0.28%
BIIB Biogen Inc.
143.95
-1.56%
GILD Gilead Sciences, Inc.
97.17
+0.23%